Double Helix

  • Date of Transaction: Jun 2012
  • Acquirer: Interpublic Group of Companies, Inc
  • Service: M&A
  • Sector: N/A

We are very pleased with this result. After a competitive sale process we identified a buyer who met our client’s price expectations and is the right strategic fit.

Gordon advised on the sale of Double Helix Bio-Technology Development Ltd, a global provider of market research and market access services to the pharmaceutical and medical device industries, to McCann Health, owned by Interpublic Group.